In contrast, in the AD group, a lower CD8+ T cells (P = 0.0119, Figure 4B) and higher CD4+/CD8+ T cell ratios (P = 0.0155, Figure 4C) correlated with better efficacy. Here, CD8A is linked to Alzheimer disease.